Follow
Timothy P. Kegelman
Timothy P. Kegelman
Department of Radiation Oncology, University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Role of excitatory amino acid transporter‐2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics
K Kim, SG Lee, TP Kegelman, ZZ Su, SK Das, R Dash, S Dasgupta, ...
Journal of cellular physiology 226 (10), 2484-2493, 2011
4602011
Astrocyte elevated gene-1 induces protective autophagy
SK Bhutia, TP Kegelman, SK Das, B Azab, Z Su, SG Lee, D Sarkar, ...
Proceedings of the National Academy of Sciences 107 (51), 22243-22248, 2010
1292010
Oncogene AEG-1 Promotes Glioma-Induced Neurodegeneration by Increasing Glutamate Excitotoxicity
SG Lee, K Kim, TP Kegelman, R Dash, SK Das, JK Choi, L Emdad, ...
Cancer research 71 (20), 6514-6523, 2011
1192011
MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma
SK Das, SK Bhutia, B Azab, TP Kegelman, L Peachy, PK Santhekadur, ...
Cancer research 73 (2), 844-854, 2013
1002013
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin
TP Kegelman, B Wu, SK Das, S Talukdar, JM Beckta, B Hu, L Emdad, ...
Proceedings of the National Academy of Sciences 114 (2), 370-375, 2017
902017
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis
SK Das, SK Bhutia, TP Kegelman, L Peachy, RA Oyesanya, S Dasgupta, ...
Front Biosci 17 (1), 1-15, 2012
872012
MDA-9/syntenin is a key regulator of glioma pathogenesis
TP Kegelman, SK Das, B Hu, MD Bacolod, CE Fuller, ME Menezes, ...
Neuro-oncology 16 (1), 50-61, 2014
692014
MDA-9/syntenin is a key regulator of glioma pathogenesis
TP Kegelman, SK Das, B Hu, MD Bacolod, CE Fuller, ME Menezes, ...
Neuro-oncology 16 (1), 50-61, 2014
692014
Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis
B Hu, L Emdad, MD Bacolod, TP Kegelman, XN Shen, MA Alzubi, SK Das, ...
Cancer research 74 (24), 7321-7332, 2014
632014
Targeting tumor invasion: the roles of MDA-9/Syntenin
TP Kegelman, SK Das, L Emdad, B Hu, ME Menezes, P Bhoopathi, ...
Expert opinion on therapeutic targets 19 (1), 97-112, 2015
592015
In vivo modeling of malignant glioma: the road to effective therapy
TP Kegelman, B Hu, L Emdad, SK Das, D Sarkar, PB Fisher
Advances in Cancer Research 121, 261-330, 2014
432014
mda‐7/IL‐24 differentially regulates soluble and nuclear clusterin in prostate cancer
SK Bhutia, SK Das, TP Kegelman, B Azab, R Dash, Z Su, XY Wang, ...
Journal of cellular physiology 227 (5), 1805-1813, 2012
402012
Astrocyte elevated Gene-1 regulates β-catenin signaling to maintain glioma stem-like stemness and self-renewal
B Hu, L Emdad, TP Kegelman, XN Shen, SK Das, D Sarkar, PB Fisher
Molecular Cancer Research 15 (2), 225-233, 2017
322017
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules
M Hedvat, L Emdad, S K Das, K Kim, S Dasgupta, S Thomas, B Hu, S Zhu, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2012
322012
AEG-1/MTDH/LYRIC: a promiscuous protein partner critical in cancer, obesity, and CNS diseases
L Emdad, SK Das, B Hu, T Kegelman, DC Kang, SG Lee, D Sarkar, ...
Advances in cancer research 131, 97-132, 2016
312016
Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy
SK Bhutia, TP Kegelman, SK Das, B Azab, ZZ Su, SG Lee, D Sarkar, ...
Autophagy 7 (5), 547-548, 2011
202011
Suppression of prostate cancer pathogenesis using an MDA-9/Syntenin (SDCBP) PDZ1 small-molecule inhibitor
SK Das, TP Kegelman, AK Pradhan, XN Shen, P Bhoopathi, S Talukdar, ...
Molecular Cancer Therapeutics 18 (11), 1997-2007, 2019
182019
The quest for an effective treatment for an intractable cancer: established and novel therapies for pancreatic Adenocarcinoma
BA Quinn, NA Lee, TP Kegelman, P Bhoopathi, L Emdad, SK Das, ...
Advances in Cancer Research 127, 283-306, 2015
142015
Factors associated with fatigue in patients with breast cancer undergoing external beam radiation therapy
MJ LaRiviere, HH Chao, A Doucette, TP Kegelman, NK Taunk, ...
Practical Radiation Oncology 10 (6), 409-422, 2020
72020
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint …
N Yegya-Raman, SH Lee, C Friedes, X Wang, M Iocolano, TP Kegelman, ...
Radiotherapy and Oncology 190, 110005, 2024
52024
The system can't perform the operation now. Try again later.
Articles 1–20